Literature DB >> 27811564

Impact of Surgical Learning Curve in Descemet Membrane Endothelial Keratoplasty on Visual Acuity Gain.

Guillaume Debellemanière1, Emmanuel Guilbert, Romain Courtin, Christophe Panthier, Patrick Sabatier, Damien Gatinel, Alain Saad.   

Abstract

PURPOSE: To evaluate the learning curve for graft preparation and graft unrolling during Descemet membrane endothelial keratoplasty (DMEK) and to assess the evolution of visual acuity gain and percentage cell loss with experience.
METHODS: The first 109 DMEK procedures performed by a single surgeon (A.S.) at the Rothschild Foundation Ophthalmology Hospital in Paris, France, between March 2012 and November 2014 were included. Best-corrected visual acuity and endothelial cell density were recorded preoperatively and again 1 week, 1 month, 3 months, and 6 months after DMEK. Donor age and ECC were registered. Graft preparation time and graft unrolling time were assessed using video recording. Incidence and types of complications were noted.
RESULTS: The number of cases necessary to reach 90% of the plateau of the learning curve was 68 for preparation time and 46 for unrolling time in this model. There was no correlation between the best-corrected visual acuity gain at 6 months postsurgery and the learning curve. The percentage cell loss was found to be significantly lower with experience (R = 0.17, P = 0.0011).
CONCLUSIONS: Surgical experience allowed faster graft preparation and faster unrolling time in DMEK. Neither experience nor percentage cell loss influenced postoperative visual acuity gain. The number of procedures needed to reach a good standard of care was estimated to be 50 in our patient database.

Entities:  

Mesh:

Year:  2017        PMID: 27811564     DOI: 10.1097/ICO.0000000000001066

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  7 in total

1.  Influence of 2D vs 3D imaging and professional experience on dental implant treatment planning.

Authors:  João Henrique Fortes; Christiano de Oliveira-Santos; Wilson Matsumoto; Raphael Jurca Gonçalves da Motta; Camila Tirapelli
Journal:  Clin Oral Investig       Date:  2018-06-16       Impact factor: 3.573

2.  Donor, Recipient, and Operative Factors Associated with Graft Success in the Cornea Preservation Time Study.

Authors:  Mark A Terry; Anthony J Aldave; Loretta B Szczotka-Flynn; Wendi Liang; Allison R Ayala; Maureen G Maguire; Christopher Croasdale; Yassine J Daoud; Steven P Dunn; Caroline K Hoover; Marian S Macsai; Thomas F Mauger; Sudeep Pramanik; George O D Rosenwasser; Jennifer Rose-Nussbaumer; R Doyle Stulting; Alan Sugar; Elmer Y Tu; David D Verdier; Sonia H Yoo; Jonathan H Lass
Journal:  Ophthalmology       Date:  2018-08-09       Impact factor: 12.079

3.  "Endothelium-Out" and "Endothelium-In" Descemet Membrane Endothelial Keratoplasty (DMEK) Graft Insertion Techniques: A Systematic Review With Meta-Analysis.

Authors:  Hon Shing Ong; Hla M Htoon; Marcus Ang; Jodhbir S Mehta
Journal:  Front Med (Lausanne)       Date:  2022-06-14

4.  Chandelier Illumination for Descemet Membrane Endothelial Keratoplasty.

Authors:  Toshiki Shimizu; Takahiko Hayashi; Kentaro Yuda; Ayako Tsuchiya; Itaru Oyakawa; Nobuhisa Mizuki; Naoko Kato
Journal:  Cornea       Date:  2017-09       Impact factor: 2.651

5.  A simplified ex vivo model to learn the correct orientation of Descemet membrane endothelial graft.

Authors:  Arjun Srirampur; Tarannum Mansoori
Journal:  Indian J Ophthalmol       Date:  2021-01       Impact factor: 1.848

6.  Evolution of corneal transplantation techniques and their indications in a French corneal transplant unit in 2000-2020.

Authors:  Vianney Malleron; Florian Bloch; Yinka Zevering; Jean-Charles Vermion; Axelle Semler-Collery; Christophe Goetz; Jean-Marc Perone
Journal:  PLoS One       Date:  2022-04-29       Impact factor: 3.240

7.  Use of Brilliant Blue G in Descemet's Membrane Endothelial Keratoplasty.

Authors:  Takahiko Hayashi; Kentaro Yuda; Itaru Oyakawa; Naoko Kato
Journal:  Biomed Res Int       Date:  2017-06-06       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.